Arbutus Biopharma Corp Quarterly Liabilities, Current in CAD from Q4 2010 to Q4 2013

Taxonomy & unit
us-gaap: CAD and USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Arbutus Biopharma Corp quarterly Liabilities, Current history and growth rate from Q4 2010 to Q4 2013.
  • Arbutus Biopharma Corp Liabilities, Current for the quarter ending December 31, 2013 was CA$12.5M, a 14.3% increase year-over-year.
Liabilities, Current, Quarterly (CAD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2013 12.5M +1.57M +14.3% Dec 31, 2013 10-K 2014-03-28
Q4 2012 11M +3.97M +56.8% Dec 31, 2012 10-K 2014-03-28
Q4 2011 6.99M -1.15M -14.1% Dec 31, 2011 20-F 2013-03-27
Q4 2010 8.13M Dec 31, 2010 20-F 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.